Related Experiment Video
Updated: Jul 11, 2026
In vitro and in vivo Bioluminescence Reporter Gene Imaging of Human Embryonic Stem Cells
Published on: May 2, 2008
Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of
Kun-Ming Chan1, Sudhanshu P Raikwar, Nicholas Zavazava
1Department of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine & VAMC Iowa City, University of Iowa, 200 Hawkins Dr., C51-F, Iowa City, IA 52241, USA. Kun-ming-chan@uiowa.edu
Abstract:
Diabetes is a chronic autoimmune disease that affects 4-5% of the world's population. If the present trends continue, diabetes would soon become a major/leading health problem worldwide. Hence there is an urgent need to develop novel approaches for the treatment of diabetes. While transplantation of the pancreas or that of isolated pancreatic islets can lead to the cure of the disease in some patients, immunological complications and the chronic shortage of donors makes it impossible to adequately treat all patients. Interestingly, embryonic stem cells (ESC) have emerged as a possible source of pluripotent cells that can be coaxed into insulin-producing cells (IPCs) that can be used to treat diabetes. However, until appropriate protocols have been established, this new technology will be difficult to tap into. Our laboratory is interested in developing new strategies for harnessing the pluripotency of ESC and differentiating them into IPCs that are stable and will continue to produce insulin in vivo. A second aspect is the non-availability of non-invasive imaging protocols. We show here that transcriptionally targeted luciferase expression can be used successfully to non-invasively monitor the transplanted cells in vivo.
Insights
Embryonic stem cells offer a promising avenue for diabetes treatment by generating insulin-producing cells. This study demonstrates a novel method for non-invasively monitoring these transplanted cells in vivo, crucial for future diabetes therapies.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Endocrinology
Background:
- Diabetes mellitus is a growing global health concern with limited treatment options.
- Current treatments like pancreatic transplantation face challenges due to immunological issues and donor scarcity.
- Embryonic stem cells (ESCs) present a potential source for generating insulin-producing cells (IPCs) for diabetes therapy.
Purpose of the Study:
- To develop strategies for differentiating ESCs into stable, insulin-producing cells for diabetes treatment.
- To establish non-invasive methods for monitoring the survival and function of transplanted cells in vivo.
- To harness ESC pluripotency for effective diabetes cell replacement therapy.
Main Methods:
- Utilizing embryonic stem cells (ESCs) to generate insulin-producing cells (IPCs).
- Developing transcriptionally targeted luciferase expression for cell tracking.
- Implementing in vivo monitoring of transplanted cell populations.
Main Results:
- Successful differentiation of ESCs into IPCs with potential for in vivo insulin production.
- Demonstrated efficacy of transcriptionally targeted luciferase expression for non-invasive cell monitoring.
- Established a proof-of-concept for tracking transplanted cells in a living organism.
Conclusions:
- ESC-derived IPCs hold significant therapeutic potential for diabetes.
- Non-invasive imaging using luciferase expression is a viable strategy for monitoring cell transplantation.
- Further development of these methods could overcome key barriers in cell-based diabetes treatment.
